Cargando…
Competing biomedical HIV prevention strategies: potential cost‐effectiveness of HIV vaccines and PrEP in Seattle, WA
INTRODUCTION: Promising HIV vaccine candidates are steadily progressing through the clinical trial pipeline. Once available, HIV vaccines will be an important complement but also potential competitor to other biomedical prevention tools such as pre‐exposure prophylaxis (PrEP). Accordingly, the value...
Autores principales: | Adamson, Blythe, Garrison, Louis, Barnabas, Ruanne V, Carlson, Josh J, Kublin, James, Dimitrov, Dobromir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689690/ https://www.ncbi.nlm.nih.gov/pubmed/31402591 http://dx.doi.org/10.1002/jia2.25373 |
Ejemplares similares
-
The Potential Cost-Effectiveness of HIV Vaccines: A Systematic Review
por: Adamson, Blythe, et al.
Publicado: (2017) -
The importance of PrEP persistence in preventing HIV infections on PrEP
por: Spinelli, Matthew A, et al.
Publicado: (2020) -
981. Extended Adherence and Persistence to HIV PrEP in a Multidisciplinary PrEP Clinic
por: Whelchel, Kristen, et al.
Publicado: (2020) -
The impact of prevention‐effective PrEP use on HIV incidence: a mathematical modelling study
por: Roberts, D. Allen, et al.
Publicado: (2022) -
Population‐level impact of expanding PrEP coverage by offering long‐acting injectable PrEP to MSM in three high‐resource settings: a model comparison analysis
por: Stansfield, Sarah E., et al.
Publicado: (2023)